GlassScriptPhysician profile
Stella M Kamanda
NPI 1164468963
$881.71
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $631 · 2020: $251.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $133.38 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $114.46 | 2019-2020 | |
| Eisai INC. | $74.99 | 2019-2020 | |
| Pfizer INC. | $57.95 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $49.06 | 2019 | |
| Lilly USA, LLC | $49.04 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $43.13 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $43.02 | 2019 | |
| Incyte Corporation | $40.86 | 2019-2020 | |
| Janssen Biotech, INC. | $35.75 | 2019-2020 | |
| Exelixis INC. | $33.50 | 2019 | |
| Celgene Corporation | $30.65 | 2019 | |
| Abbvie INC. | $28.75 | 2019 | |
| Secura Bio, INC. | $25.72 | 2019 | |
| Glaxosmithkline, LLC. | $23.61 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Foundation Medicine, INC. | $15.47 | 2019 | |
| Genentech USA, INC. | $15.07 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.49 | 2020 | |
| Novartis Pharmaceuticals Corporation | $14.18 | 2019 | |
| Gilead Sciences, INC. | $13.67 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.00 | 2019 | |
| Alexion Pharmaceuticals, INC. | $11.96 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stella Kamanda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.